Search Within

Eun Jung Cho

Formats
  1. Meeting Abstract (4)
  2. Journal Article (1)
Groups
  1. Department of Medicine (5)
  2. GSK Faculty (5)
  3. Human Oncology and Pathogenesis Program (5)
  4. Solid Tumor Oncology Division (5)
  5. Tow Center for Developmental Oncology (TCDO) (5)
  6. Department of Pathology and Laboratory Medicine (4)

More Groups

People
  1. Marc Ladanyi (4)
  2. Alexander Drilon (3)
  3. Lu Wang (3)
  4. Naiyer Rizvi (3)
  5. Mark Kris (2)
  6. Aaron Viny (1)

More People

Years
  1. 2014 (4)
  2. 2013 (1)
Publications
  1. Journal of Clinical Oncology (3)
  2. Journal of Thoracic Oncology (1)
  3. Nature (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. Elsevier Inc. (1)
  3. Nature Publishing Group (1)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Predictors of overall survival in patients diagnosed with desmoplastic small round cell tumor (DSRCT)
    Meeting Abstract

    Shoushtari, A. N.; Qin, L. X.; Kuk, D.; Magnan, H. D.; Modak, S.; Wolden, S. L.; Cho, E. J.; Pallos, V.; Grubman, O.; Viny, A. D.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Clinicopathologic features of advanced RET fusion-positive lung cancers and outcomes in comparison to other fusion-positive lung cancers
    Meeting Abstract

    Drilon, A. E.; Hellmann, M. D.; Wang, L.; Cho, E. J.; Ladanyi, M.; Rizvi, N. A.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Next-generation sequencing (NGS) to identify actionable genomic alterations (GA) in "pan-negative" lung adenocarcinomas (ADC) from patients with no smoking or a light smoking (NS/LS) history
    Meeting Abstract

    Drilon, A. E.; Wang, L.; Arcila, M. E.; Cho, E. J.; Balasubramanian, S.; Greenbowe, J. R.; Ross, J. S.; Stephens, P.; Lipson, D.; Miller, V. A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Comprehensive molecular characterization of gastric adenocarcinoma
    Journal Article

    The Cancer Genome Atlas Research Network
    Nature (2014)

    Fulltext@MSK | Save
  • Ret fusion-positive advanced lung cancers: Response to first-line chemotherapy and survival in comparison to ROS1 and ALK fusion-positive and EGFR- and KRAS-mutant lung cancers
    Meeting Abstract

    Drilon, A.; Wang, L.; Joubert, P.; Snyder, A.; Cho, E. J.; Riely, G.; Kris, M.; Ladanyi, M.; Rizvi, N.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save